Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes

We investigated characteristics associated with the efficacy of dipeptidyl peptidase-4 inhibitors (DPP4i) in Korean patients with type 2 diabetes. We reviewed medical records of 477 patients who had taken sitagliptin or vildagliptin longer than 40 weeks. Response to DPP4i was evaluated with HbA1c ch...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Oh, Tae Jung, Jung, Hye Seung, Bae, Jae Hyun, Kim, Yeong Gi, Park, Kyeong Seon, Cho, Young Min, Park, Kyong Soo, Kim, Seong Yeon
Format: Artigo
Język:Inglês
Wydane: The Korean Academy of Medical Sciences 2013
Hasła przedmiotowe:
Original Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3678005/
https://ncbi.nlm.nih.gov/pubmed/23772153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2013.28.6.881
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy